Keyphrases
Indonesia
100%
Jakarta
28%
Lymphatic Filariasis
22%
Albendazole
22%
Brugia Malayi
18%
Plasmodium Falciparum
17%
Falciparum Malaria
17%
Plasmodium Vivax
17%
Primaquine
16%
Malaria
13%
Helminth Infection
13%
Mass Drug Administration
13%
Microfilaria
12%
Diethylcarbamazine
12%
Helminths
11%
Indonesian
10%
Filarial Parasites
10%
Type 2 Diabetes Mellitus (T2DM)
9%
Brugia
9%
Brugia Timori
9%
Chronic Pulmonary Aspergillosis
9%
Interleukin-10
9%
Soil-transmitted Helminth Infections
8%
Soil-transmitted Helminths
8%
Randomized Placebo-controlled Trial
8%
Immune Response
8%
Schoolchildren
8%
Filarial
8%
Elephantiasis
7%
Randomized Controlled Trial
7%
Radical Cure
7%
Hyaluronic Acid
7%
Deworming
7%
Diabetic Foot Ulcer
7%
Cluster Randomized Trial
7%
Platelet-rich Fibrin
7%
Intestinal Parasitic Infections
7%
IgG4-related Disease (IgG4-RD)
7%
Placebo
7%
Filariasis
6%
Dengue Fever
6%
Aspergillus
6%
Ascaris Lumbricoides
6%
Irian Jaya
6%
Southwest Sumba
6%
Propolis
6%
Interleukin-6
6%
Interferon-α (IFN-α)
6%
Toxoplasma Gondii (T. gondii)
6%
IgG4 Antibodies
6%
Risk Factors
6%
Pada
6%
Filaria
6%
Permethrin
6%
Quantitative PCR
6%
HIV Patients
6%
Stool Samples
6%
Diarrhea
6%
Eastern Indonesia
6%
Wuchereria Bancrofti
5%
Parasitemia
5%
AIDS/HIV
5%
Cryptosporidium
5%
Peripheral Blood Mononuclear Cells
5%
Adult Worm
5%
Candida Albicans (C. albicans)
5%
Filarial Nematodes
5%
Lymphatics
5%
Individual Patient Data Meta-analysis
5%
Flores Island
5%
Artemisinin-based Combination Therapy
5%
Infection Rate
5%
Insulin Resistance
5%
Candida
5%
Tuberculosis Patients
5%
T Cells
5%
Dari
5%
Anthelmintic Treatment
5%
Chloroquine
5%
Pulmonary Tuberculosis
5%
Stool
5%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
24%
Prevalence
23%
Primaquine
17%
Albendazole
17%
Placebo
13%
Helminthiasis
13%
Disease
13%
Drug Administration
12%
Helminth
12%
Malaria Falciparum
12%
Lymphatic Filariasis
11%
Plasmodium Vivax Malaria
11%
Randomized Controlled Trial
11%
Antimalarial Agent
9%
Plasmodium vivax
9%
Aspergillus
8%
Candida Albicans
8%
Propolis
8%
Diethylcarbamazine
8%
Candida
8%
Cross-Sectional Study
7%
Antifungal Agent
7%
Plasmodium falciparum
7%
HIV
7%
Parasitemia
7%
Artemisinin
7%
Combination Therapy
7%
Parasitosis
6%
Adverse Event
6%
Tumor Necrosis Factor
6%
Lung Aspergillosis
6%
Platelet-Rich Fibrin
6%
foot ulcer, diabetic
6%
Inflammation
6%
Symptom
6%
Brugian Filariasis
6%
Microfilaria
6%
Enzyme-Linked Immunosorbent Assay
6%
Antifungal Activity
6%
Anemia
6%
Filariasis
5%
Hyaluronic Acid
5%
Chloroquine
5%
Non Insulin Dependent Diabetes Mellitus
5%
Recurrent Disease
5%
Medicine and Dentistry
Infection
16%
Prevalence
13%
Helminthiasis
13%
Helminth
13%
Albendazole
11%
Lymphatic Filariasis
11%
Parasite (Microbiology)
10%
Parasitic Disease
8%
Drug Administration
8%
Disease
8%
Intestinal Parasite
8%
Human Immunodeficiency Virus
8%
Diabetic Foot Ulcer
7%
Platelet-Rich Fibrin
7%
Diarrhea
7%
Placebo
6%
Brugia malayi
6%
Randomized Controlled Trial
6%
Restylane
6%
Malaria Falciparum
6%
Diethylcarbamazine
6%
Maturity Onset Diabetes of the Young
5%
Insulin Resistance
5%
Systematic Review
5%
Cross Sectional Study
5%
Polymerase Chain Reaction
5%
Antihelminthic Therapy
5%
COVID-19
5%
Filariasis
5%